856 Routine baseline blood tests predicting pembrolizumab sensitivity in advanced high-grade serous ovarian cancer (AHGSOC) 1st line therapy: substudy from the NEOPEMBROV/GINECO (NCT03275506) randomized trialStanislas Quesada,Isabelle Ray-Coquard,Camille Schiffler,Aude-Marie Savoye,Marie-Ange Mouret-Reynier,Florence Joly, Olfa Derbel Miled,Elsa Kalbacher,Alejandra Martinez,Marianne Leheurteur,Jérôme Meunier,MAthilde Martinez, Nicolas Cloarec,Laurence Venat-Bouvet, Dominique Berton,Frédéric Selle,Pierre-Alexandre Just,Guillaume Bataillon,Isabelle Treilleux,Olivia Le SauxPoster and E-Posters(2024)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要